{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-032511","form_type":"8-K","ticker":"TMCI","cik":"0001630627","company_name":"TREACE MEDICAL CONCEPTS, INC.","filed_at":"2023-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.926132+00:00","generated_at":"2026-06-19T18:03:01.755842+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Treace Medical closes public offering of 5.48M shares, net proceeds ~$107.5M","bullets":["Offering of 5,476,190 shares (including full overallotment) at $21.00/share to the public.","Net proceeds of $107.5M after underwriting discounts and estimated offering expenses.","Underwriters purchased shares at $19.74/share; 90-day lock-up for insiders.","Underwritten by J.P. Morgan and Morgan Stanley; shelf registration on Form S-3 used."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-032511","json":"https://secwatch.observer/filing/0001193125-23-032511.json","markdown":"https://secwatch.observer/filing/0001193125-23-032511.md","text":"https://secwatch.observer/filing/0001193125-23-032511.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630627/000119312523032511/0001193125-23-032511-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630627/000119312523032511/d457581d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T18:03:01.755842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c4637717da9329747b4c42d5e7bb756b24a2fef","claim":"TREACE MEDICAL CONCEPTS, INC. entered into Underwriting Agreement with J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC valued at Issuance and sale of 4,761,905 shares of common stock at $21.00 per share to public, underwriters pu (effective 2023-02-07).","evidence_excerpt":"On February 7, 2023, Treace Medical Concepts, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, as representatives (the “Representatives”) of the several underwriters named therein (collectively, the “Underwriters”), pursuant to which the Company agreed to issue and sell 4,761,905 shares (the “Firm Shares”) of its common stock, par value $0.001 per share (“Common Stock”), to the Underwriters (the “Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312523032511/0001193125-23-032511-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC"},{"label":"Value","value":"Issuance and sale of 4,761,905 shares of common stock at $21.00 per share to public, underwriters pu"},{"label":"Effective","value":"2023-02-07"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}